RD
RedHill Biopharma Ltd.
RDHL · NASDAQ
$0.64 -1.54% (-$0.01)
1M +10.73%
Market Cap $2.05M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.71
10.1% upside
Trenutna cena
$0.64
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RDHL trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.21x
P/B 0.48x
P/E N/A
Growth
0 /100
Declining Rev. growth 83.34%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 64.45%
Net margin 97.52%
Op. margin 110.40%
Quality
7 /100
Poor ROIC 167.51%
ROA 36.74%
Asset turnover 0.38x
Debt
46 /100
Moderate Debt/Equity 0.25x
Current ratio 0.34x
Int. coverage -7.99x
Stability
1 /100
Unstable Beta 4.90x
Rev. volatility 67.13%
EPS volatility 126.53%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RDHL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dror Ben-Asher
Employees
13
Headquarters
Tel Aviv
Prihajajoči dogodki
18 MAR.
Earnings
Upcoming earnings report